Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1936 1
1958 1
1959 1
1963 1
1964 2
1965 1
1966 2
1967 4
1971 3
1972 6
1973 2
1974 7
1975 5
1976 8
1977 3
1978 6
1979 3
1980 11
1981 6
1982 5
1983 9
1984 5
1985 9
1986 15
1987 18
1988 25
1989 20
1990 24
1991 20
1992 39
1993 24
1994 42
1995 34
1996 24
1997 32
1998 18
1999 28
2000 28
2001 51
2002 71
2003 75
2004 97
2005 110
2006 149
2007 147
2008 141
2009 174
2010 235
2011 252
2012 277
2013 276
2014 308
2015 278
2016 321
2017 397
2018 410
2019 485
2020 560
2021 575
2022 645
2023 526
2024 468

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,659 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD; SPIRIT-P1 Study Group. Mease PJ, et al. Among authors: lin cy. Ann Rheum Dis. 2017 Jan;76(1):79-87. doi: 10.1136/annrheumdis-2016-209709. Epub 2016 Aug 23. Ann Rheum Dis. 2017. PMID: 27553214 Free PMC article. Clinical Trial.
Reply.
Lin CY, Hsu CY. Lin CY, et al. Arthritis Rheumatol. 2022 Apr;74(4):730-731. doi: 10.1002/art.42026. Epub 2022 Feb 20. Arthritis Rheumatol. 2022. PMID: 34807504 No abstract available.
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
Simpson E, Bissonnette R, Eichenfield LF, Guttman-Yassky E, King B, Silverberg JI, Beck LA, Bieber T, Reich K, Kabashima K, Seyger M, Siegfried E, Stingl G, Feldman SR, Menter A, van de Kerkhof P, Yosipovitch G, Paul C, Martel P, Dubost-Brama A, Armstrong J, Chavda R, Frey S, Joubert Y, Milutinovic M, Parneix A, Teixeira HD, Lin CY, Sun L, Klekotka P, Nickoloff B, Dutronc Y, Mallbris L, Janes JM, DeLozier AM, Nunes FP, Paller AS. Simpson E, et al. Among authors: lin cy. J Am Acad Dermatol. 2020 Sep;83(3):839-846. doi: 10.1016/j.jaad.2020.04.104. Epub 2020 Apr 25. J Am Acad Dermatol. 2020. PMID: 32344071
Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2.
Roubidoux EK, Brigleb PH, Vegesana K, Souquette A, Whitt K, Freiden P; St. Jude Investigative Team; Green A, Thomas PG, McGargill MA, Wolf J, Schultz-Cherry S. Roubidoux EK, et al. Sci Rep. 2023 Oct 19;13(1):17820. doi: 10.1038/s41598-023-44989-5. Sci Rep. 2023. PMID: 37857783 Free PMC article.
Effusive Tuberculous Pericarditis.
Zheng XZ, Tsai YT, Lin CY, Tsai CS, Lin YC. Zheng XZ, et al. Among authors: lin cy. Ann Thorac Surg. 2017 Nov;104(5):e397. doi: 10.1016/j.athoracsur.2017.07.010. Ann Thorac Surg. 2017. PMID: 29054238 No abstract available.
COVID-19 vaccine-induced encephalitis and status epilepticus.
Fan HT, Lin YY, Chiang WF, Lin CY, Chen MH, Wu KA, Chan JS, Kao YH, Shyu HY, Hsiao PJ. Fan HT, et al. Among authors: lin cy. QJM. 2022 Feb 21;115(2):91-93. doi: 10.1093/qjmed/hcab335. QJM. 2022. PMID: 34978572 Free PMC article. No abstract available.
An oncogenic enhancer encodes selective selenium dependency in AML.
Eagle K, Jiang Y, Shi X, Li M, Obholzer NP, Hu T, Perez MW, Koren JV, Kitano A, Yi JS, Lin CY, Nakada D. Eagle K, et al. Among authors: lin cy. Cell Stem Cell. 2022 Mar 3;29(3):386-399.e7. doi: 10.1016/j.stem.2022.01.003. Epub 2022 Feb 1. Cell Stem Cell. 2022. PMID: 35108519 Free PMC article.
6,659 results